Last reviewed · How we verify

NCT04990518: Phydel

Physical Deconditioning in COVID-19 Positive Patients and Non-Specific Low Back Pain

Terminated Last updated 9 November 2022
What this trial tests

trial in Low Back Pain, Mechanical in 350 participants. Terminated before completion.

Timeline
5 November 2022
Primary endpoint
5 November 2022
5 November 2022

Quick facts

Lead sponsorUniversity Hospital, Geneva
StatusTerminated
Study typeOBSERVATIONAL
Enrollment350
Start date5 November 2022
Primary completion5 November 2022
Estimated completion5 November 2022
Sites1 location across Switzerland

Conditions studied

Sponsor

University Hospital, Geneva

Who can join

Adults 18 to 65, any sex, with Low Back Pain, Mechanical. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to take advantage of cohorts of patients followed for Coronavirus Disease 2019 (COVID19) expected to present poor physical fitness as the consequence of COVID19 to explore the relationship between physical fitness and low back pain (LBP). Level of physical fitness will be measured at baseline and incidence and intensity of LBP will be recoreded over 1 year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Low Back Pain, Mechanical

Currently open trials in the same condition.

Other University Hospital, Geneva trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04990518.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing